Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000913414-09-003378
Filing Date
2009-02-05
Accepted
2009-02-05 13:27:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 enzon123108.txt SC 13G 31816
  Complete submission text file 0000913414-09-003378.txt   34537
Mailing Address 685 ROUTE 202/206 ATT: GENERAL COUNSEL BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 908 541 8671
ENZON PHARMACEUTICALS INC (Subject) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-35587 | Film No.: 09571513
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 400 HOWARD STREET SAN FRANCISCO CA 94105
Business Address 400 HOWARD STREET SAN FRANCISCO CA 94105 4155972639
BARCLAYS GLOBAL INVESTORS NA /CA/ (Filed by) CIK: 0000913414 (see all company filings)

EIN.: 943112180 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G
SIC: 0000